XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.3
Statements of Operations and Comprehensive Loss - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Statements of Operations and Comprehensive Loss        
Revenue from collaboration and license agreements       $ 75,000
Costs and expenses:        
Research and development expense $ 5,291,790 $ 4,922,857 $ 14,783,204 22,500,058
General and administrative expense 4,521,706 3,844,579 14,901,255 14,355,644
Total costs and expenses 9,813,496 8,767,436 29,684,459 36,855,702
Loss from operations (9,813,496) (8,767,436) (29,684,459) (36,780,702)
Interest income 610,978 243,597 1,863,679 336,255
Net loss and comprehensive loss $ (9,202,518) $ (8,523,839) $ (27,820,780) $ (36,444,447)
Basic net loss per common share (in dollars per share) $ (0.14) $ (0.16) $ (0.44) $ (0.70)
Diluted net loss per common share (in dollars per share) $ (0.14) $ (0.16) $ (0.44) $ (0.70)
Basic weighted-average number of common shares outstanding (in shares) 64,349,709 52,423,944 62,992,006 52,387,561
Diluted weighted-average number of common shares outstanding (in shares) 64,349,709 52,423,944 62,992,006 52,387,561